Alpha Cognition Inc. (ACOG)
$9.12-$0.57 (-5.91%) Today
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 15 | 464,116 | $3.35M |
37 Form 4 filings on record, the earliest from Nov 15, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Henry Huy Du - Officer | Grant or award | Common Shares | 20,579 | $0.00 | - | |
| Henry Huy Du - Officer | Grant or award | Common Share Options | 15,982 | $0.00 | - | |
| Robert James Wills | Open-market purchase | Common Stock | 15,000 | $8.49 | $127K | |
| Leonard Powell Mertz | Open-market purchase | Common Shares | 27,778 | $9.00 | $250K | |
| Phillip Joseph Mertz | Open-market sale | Common Shares | 27,778 | $9.00 | $250K | |
| Michael E. McFadden - Officer | Open-market purchase | Common Shares | 2,608 | $5.75 | $15K | |
| Leonard Powell Mertz | Open-market purchase | Common Shares | 8,695 | $5.75 | $50K | |
| John Prentiss Havens | Open-market purchase | Common Shares | 4,347 | $5.75 | $25K |
This is as far as the anonymous view goes. Create a free account for all 37 ACOG filings on record.
Alpha Cognition Inc. (ACOG) had 8 insider filings in the last 90 days, with the most recent on 2026-08-24. The full record for ACOG runs to 37 Form 4 filings, the earliest from 2024-11-15. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
15 insider purchases of ACOG were filed in the last 90 days, totaling $3.35M.
No insider sales of ACOG were filed in the last 90 days. 1 sale is on record for this company.
This page tracks ACOG Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add ACOG to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
